论文信息 - Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project - 字舞流文

Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project

K. Manos | Jock D Simpson | N. Viiala | T. Armytage | C. Keane | Callum Birks | A. Johnston | A. Barraclough | S. Ratnasingam | E. Hawkes | M. Ku | C. Wellard | Denise Lee | R. Bennett | E. Chung | B. Shaw | E. Yoo | C. Cheah | N. Hamad | Stephen Opat | T. Cochrane | Geoffrey Chong | Stephanie Wallwork